NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Use of blue dye for sentinel lymph node biopsy should be minimized



October 20th, 2005

Although blue dye for sentinel lymph node biopsy in breast cancer provided marginal benefits, its use should be minimized due to allergic reaction.

"The use of isosulfan blue dye in sentinel node biopsy for breast cancer has been questioned because of its risk of allergic reaction. We hypothesized that blue dye could be safely omitted in the subgroup of patients who have evidence of successful sentinel node localization by lymphoscintigraphy. A retrospective review of patients with breast cancer and sentinel node biopsy was conducted," scientists in the United States reported.

"Information was collected on lymphoscintigraphy results, use of blue dye,...


Source: Women's Health Weekly (2005-10-20)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login